Drug-induced cranial myoclonus

Movement Disorders

Volumn 25, Issue 13, 2010, Pages 2264-2265

  Gupta, Amitabh ^a   Lang, Anthony E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMFEBUTAMONE; CITALOPRAM; CLONAZEPAM; LEVODOPA; PRAMIPEXOLE; RISPERIDONE; ROSUVASTATIN;

ADULT; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MALE; MYOCLONUS; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SPINE INSTABILITY; STUTTERING; TREMOR;

AGED; ANTIDEPRESSIVE AGENTS; ANTIPARKINSON AGENTS; DEPRESSION; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MYOCLONUS; PARKINSONIAN DISORDERS;

EID: 78649349873     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23140     Document Type: Letter

References (7)

1. Pfeiffer RF. Amantadine-induced "vocal" myoclonus. Mov Disord 1996;11:104-106.
2. Frucht S, Fahn S. The clinical spectrum of posthypoxic myoclonus. Mov Disord 2000;15(Suppl 1):2-7.
3. Gelfand JM, Nelson AB, Fross RD, Glass GA. Speech-activated myoclonus masquerading as stuttering. Neurology 2009;72:1964.
4. Brotchie JM. Nondopaminergic mechanisms in levodopa-induced dyskinesia. Mov Disord. 2005;20:919-931.
5. Placzek AN, Zhang TA, Dani JA. Age dependent nicotinic influences over, dopamine neuron synaptic plasticity. Biochem Pharmacol 2009;78:686-692.
6. Lee FJ, Xue S, Pei L, et al. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 2002;111:219-230.
7. Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC. GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology 2009;56:915-921.